Penn spinout Tmunity Therapeutics raises another $35M

The Philadelphia cell therapy company's series A financing has grown to $135 million. Tmunity is developing immunotherapies that target solid tumors.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.